News | Radiation Oncology | February 03, 2022

ASTRO supports investments to accelerate research and screening that will improve outcomes for people with cancer

The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board of Directors Chair Laura A. Dawson, M.D., FASTRO, in response to today's announcement that President Joe Biden will reignite the Cancer Moonshot initiative to accelerate the rate of progress in the nation's fight against cancer

February 3, 2022 — The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board of Directors Chair Laura A. Dawson, M.D., FASTRO, in response to today's announcement that President Joe Biden will reignite the Cancer Moonshot initiative to accelerate the rate of progress in the nation's fight against cancer:

"On behalf of radiation oncologists who treat people with cancer every day, we support the Biden-Harris administration's move to drastically reduce the number of cancer deaths in the United States and improve the lives of people diagnosed with this disease. We believe the administration’s commitment to expand cancer prevention efforts and to increase equitable access to screenings and treatments will help mitigate some of the negative impact of the COVID-19 pandemic. ASTRO and the radiation oncology community stand ready to work with the Administration to realize these goals.

In the past two decades, bipartisan support for the cancer care community contributed to averting nearly three million deaths in the U.S., but the COVID-19 pandemic upended nearly all aspects of this important work. Clinical trials were halted, screening and treatments were delayed, and resources were diverted from research that leads to a reduction in cancer mortality. The numbers of cancer cases and deaths in the U.S. are expected to rise due to the sharp decline in screenings during the pandemic, driving the need for a comprehensive federal response to mitigate the impact of COVID-19 on cancer research and patient care.

In a 2021 ASTRO national survey of radiation oncologists, 66% said their patients are being diagnosed with more advanced-stage cancers, and 73% said they noticed missed screenings among their patients. These rates may be even higher for racial and ethnic minority groups, who face disproportionate burdens regarding both COVID-19 and cancer. Multiple studies show that inequitable access is driving disparate outcomes. Today's announcement highlights the critical need for multidisciplinary collaboration and prioritization of cancer research and screening to reverse these alarming trends.

The radiation oncology community shares President Biden's goals of ending cancer as we know it today and bolstering research funding so that the lives of people with cancer and their families improve." 

ASTRO is pleased that the Administration recognized the critical role radiation oncology plays in the fight against cancer by inviting Karen M. Winkfield, MD, PhD, a member of the National Cancer Advisory Board and a leading expert in radiation oncology, cancer disparities and community engagement, to participate in today’s White House event.

ASTRO and other members of the Once Voice Against Cancer coalition sent a letter to Congressional leadership yesterday calling for swift passage of a fiscal year 2022 spending package that includes strong support for the National Institutes of Health (NIH) and the National Cancer Institute (NCI).

For more information: www.astro.org

Related Cancer Moonshot information:

President's Cancer Panel Calls for Urgent Action to Address Gaps in Cancer Screening Uptake

Related content on cancer screening:

Racial/Ethnic Disparities Persist in Lung Cancer Screening Eligibility

Primary Lung Cancers Detected by LDCT are at Lower Risk of Brain Metastases

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage

USPSTF Expands Lung Cancer Screening Eligibility Thresholds 

Low-dose CT for Lung Cancer Screening: Benefit Outweighs Potential Harm


Related Content

News | Magnetic Resonance Imaging (MRI)

February 21, 2024 — Hyperfine, Inc., a groundbreaking health technology company that has redefined brain imaging with ...

Time February 21, 2024
arrow
News | Radiopharmaceuticals and Tracers

February 21, 2024 — Blue Earth Therapeutics, a Bracco company and emerging leader in the development of innovative next ...

Time February 21, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 16, 2024 — Fujifilm Healthcare Europe will be presenting the Echelon Synergy – a revolutionary MRI scanner for ...

Time February 16, 2024
arrow
News | SPECT Imaging

February 15, 2024 — According to a release issued by the U.S. Food and Drug Administration (FDA), Philips is recalling ...

Time February 15, 2024
arrow
News | Ultrasound Imaging

February 15, 2024 — Clarius Mobile Health, a global leader in wireless ultrasound solutions, announces T-Mode AI, a ...

Time February 15, 2024
arrow
News | Ultrasound Imaging

February 15, 2024 — According to the American Journal of Roentgenology (AJR), 10 abdominal radiologists showed ...

Time February 15, 2024
arrow
News | ACR

February 13, 2024 — The American College of Radiology (ACR) has announced that Mark Alson, MD, FACR, RCC, was presented ...

Time February 13, 2024
arrow
News | Quality Assurance (QA)

February 12, 2024 — IBA, a world leader in particle accelerator technology and a world-leading provider of dosimetry and ...

Time February 12, 2024
arrow
Sponsored Content | Videos | Digital Radiography (DR)

Agfa Radiology Solutions is committed to enhancing clinical outcomes and operational efficiency, underscoring its ...

Time February 12, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

February 9, 2024 — Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It ...

Time February 09, 2024
arrow
Subscribe Now